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Posterior Capsule Opacification: What’s in the Bag? 
Abstract  
Cataract, a clouding of the lens, is the most common cause of blindness in the world. It has a 
marked impact on the wellbeing and productivity of individuals and has a major economic 
impact on healthcare providers. The only means of treating cataract is by surgical 
intervention. A modern cataract operation generates  capsular bag, which comprises a 
proportion of the anterior capsule and the entire posterior capsule. The bag remains in situ, 
partitions the aqueous and vitreous humours, and in the majority of cases, houses an 
intraocular lens (IOL). The production of a capsular b g following surgery permits a free 
passage of light along the visual axis through the transparent intraocular lens and thin 
acellular posterior capsule. Lens epithelial cells, however, remain attached to the anterior 
capsule, and in response to surgical trauma initiate a wound-healing response that ultimately 
leads to light scatter and a reduction in visual quality known as posterior capsule 
opacification (PCO). There are two commonly-described forms of PCO: fibrotic and 
regenerative. Fibrotic PCO follows classically defin d fibrotic processes, namely 
hyperproliferation, matrix contraction, matrix deposition and epithelial cell trans-
differentiation to a myofibroblast phenotype. Regenerative PCO is defined by lens fibre cell 
differentiation events that give rise to Soemmerring’s ring and Elschnig’s pearls and becomes 
evident at a later stage than the fibrotic form. Both fibrotic and regenerative forms of PCO 
contribute to a reduction in visual quality in patients. This review will highlight the wealth of 
tools available for PCO research, provide insight into our current knowledge of PCO and 
discuss putative management of PCO from IOL design to pharmacological interventions.  
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Cataract - a clouding of the lens - is the most comm n cause of blindness in the world. It has 
a marked impact on the wellbeing and productivity of individuals and carries a major 
economic cost to healthcare providers (Brown et al., 2013; Resnikoff et al., 2004). 
Appropriate dietary intake and behavioural traits can help protect the lens and delay cataract 
formation, but ultimately cannot prevent the appearance of cataract if an individual is blessed 
with longevity. Recent reports in high profile journals have suggested agents could be used to 
treat nuclear cataract through disaggregation of crystallins (Cleary et al., 2010; Zhao et al., 
2015), but this putative treatment still requires significant development and evaluation before 
these agents can be considered a reasonable therapeutic option. In the near future, the only 
means of treating cataract is by surgical intervention, which initially restores high visual 
quality. Unfortunately, a secondary loss of vision, termed posterior capsule opacification 
(PCO), develops in a significant proportion of patien s post-surgery (Nibourg et al., 2015; 
Wormstone and Eldred, 2016). The text that follows aims to provide a background of events 
following cataract surgery, the study systems that can inform and lead to better understanding 
of the condition, the regulatory mechanisms involved and efforts directed to  improve the 
management of PCO. 
 
1.1 Cataract surgery 
A modern cataract operation involves making a small incision in the sclera or cornea to 
permit introduction of surgical tools with minimal physical disruption to the eye. An opening 
in the lens is made by continuous curvilinear capsulorhexis (capsular tear) in the anterior 
capsule. This is usually achieved with a capsulotome, however, femtosecond laser is also 
adopted by some surgeons, which in principle provides an anterior opening that is more 








anterior capsule allows access to the central lens fibres, which are usually removed by 
phacoemulsification. In some cases, this process is a sisted by femtosecond laser treatment 
and if required, traditional hydrodissection methods can be used. Residual fibre cells are 
removed by irrigation/aspiration. The product of catar ct surgery is a capsular bag. This 
comprises a portion of the anterior and the entire posterior capsule. The bag remains in situ, 
partitions the aqueous and vitreous humours, and in the majority of cases, houses an 
intraocular lens (IOL). The production of a capsular b g following surgery permits a free 
passage of light along the visual axis through the transparent IOL and thin acellular posterior 
capsule (Figure 1A).  
 
1.2 Post-surgical wound-healing and PCO 
Despite the initial success of cataract surgery, it has long been known that nature fights back 
(Eldred et al., 2011; McDonnell et al., 1983; Nibourg et al., 2015; Saika, 2004; Wilhelmus 
and Emery, 1980; Wormstone and Eldred, 2016; Worst, 1977). Cataract surgery, however 
skilfully performed, is a controlled trauma to the eye. This disruption to the integrity of the 
eye invokes a raft of environmental and physical changes that instigate a wound-healing 
response. This fundamentally centres on an attempt to repair the damaged tissue, which in 
this case is the lens.  Despite the physical stresses and strains placed upon the lens during 
cataract surgery, a proportion of the lens epithelium remain viable (Figure 1A). These 
surviving cells start to repopulate denuded regions f the anterior capsule, followed by 
growth over all available surfaces, including the IOL surface; the outer anterior capsule; and 
of primary importance the previously cell-free posterior capsule (Figure 1B). Cells continue 
to divide, begin to cover the posterior capsule and can ultimately encroach on the visual axis. 
A homogenous thin cover of cells is unlikely to affect the light path significantly, but 









common changes with regard the all-important visual axis result from fibrosis: this is 
generally associated with matrix deposition, wrinkli g/contraction of the posterior capsule, 
increased cell aggregation and increased presence of my fibroblasts (Figure 1B). This is 
referred to as the fibrotic form of PCO (Eldred et al., 2011). It is likely all patients undergo 
some level of fibrosis in response to surgery. In time, a number of patients will also present 
features attributed to a second category of the conditi , known as regenerative PCO (Figure 
1C).  This is characterised by the formation of swollen globular cells known as Elschnig’s 
pearls, which are believed to be the product of aberr nt differentiation. These structures can 
encroach upon the visual axis and cause significant visual disruption (Findl et al., 2010; 
Kappelhof et al., 1987; Sveinsson, 1993; van Bree et al., 2011). In addition, lens fibre 
differentiation can occur in the peripheral capsular b g and is known as Soemmerring’s ring 
(Findl et al., 2010; Kappelhof et al., 1987; van Bree et al., 2011). While both fibrotic and 
regenerative PCO contribute to visual disturbance, th  regenerative form is the most severe 
(van Bree et al., 2011). Additional features can also contribute to visual deterioration, 
including cell growth on the IOL surface, anterior fibrosis and anterior capsular phimosis 
(Mullner-Eidenbock et al., 2001; Sciscio and Liu, 1999; Waheed et al., 2001). Ultimately, if 
these changes are sufficiently severe then visual impairment will ensue and corrective 
Nd:YAG laser capsulotomy surgery will be required.. Recent reports suggest the proportion 
of patients requiring laser capsulotomy three years after standard surgery is between 5 and 
20% (Leydolt et al., 2020; Ursell et al., 2020). However, these figures are influenced by a 












A multitude of approaches can be employed to gain an understanding of the regulatory 
processes that drive PCO and to evaluate and develop management strategies. These tools 
range from pure clinical data to simple cell cultures. Each approach has its benefits and 
limitations and it is important to consider these relative properties when predicting outcomes 
in patients, both human and animal. In the following section, a range of study tools will be 
introduced that will provide context for later sections that will describe our current 
understanding of PCO and the application of this information for PCO management. 
 
2.1. Clinical data 
Clinical trials performed to evaluate intraocular lenses provide indication of the influence 
different IOLs may have on PCO (Leydolt et al., 2020; Perez-Vives, 2018; Ursell et al., 
2020). Many of these studies and retrospective analysis of such studies use Nd:YAG 
capsulotomy as an indication of PCO incidence. The majority of clinical studies have 
exclusion criteria to allow better comparison of data sets, therefore probably underrepresent 
the incidence of PCO across the general population. T  aid assessment of PCO progression 
prior to Nd:YAG capsulotomy various imaging systems have been developed, with 
retroillumination the most commonly used for monitoring PCO in patients (Hollick et al., 
2000; Leydolt et al., 2020). To better utilise the images and establish numerical assessment, 
analysis software such as EPCO and AQUA II (Kronschlager et al., 2019) have been 
developed. Typical clinical trials capture patient information at significant time-points, e.g. 1 
month, 3 months, 6 months, 1 year, 2 years, 3 years which enables general patterns to be 
observed, including (but not limited to): PCO scale nd type (fibrotic and/or regenerative 
PCO); IOL decentration; IOL tilt; visual axis opacifi ation (Ursell et al., 2020, Leydolt et al., 
2020 (Ale, 2011)). These studies provide general patterns and outcomes, but understanding 









Ursell et al., 2020). Projects have been performed to assess specific clinical events, such as 
Elschnig’s pearl dynamics (Findl et al., 2010). Information such as this is invaluable and 
work of this nature should stimulate basic researchers to mimic such changes in their 
respective experimental models in order to establish the molecular and physiological basis for 
these phenomena. 
 
2.2. Clinician and patient views 
It is curious that little information is available that reports surgical opinion regarding PCO. In 
a recent survey of both human and veterinary ophthalmologists, there was common 
recognition that PCO was a significant problem associated with cataract surgery. Even with 
advances in IOL design, opinion supported the pursuit of additional management strategies 
using therapeutic agents or additional surgical approaches (Shihan et al., 2019). Clinicians 
play a key role in assessing PCO development within patients. They are the individuals 
providing direct care for patients and further engagement and knowledge exchange between 
clinicians, biologists and engineers is likely to enhance the provision of care in the future. 
Surprisingly, an opinion often neglected(but one which would provide great insight) is that of 
the patient. There are very few studies that present the viewpoint of patients with respect to 
PCO and how it affects wellbeing (Addisu and Solomon, 2011; Salerno et al., 2017). PCO is 
often talked about in numerical terms, but for many patients it is debilitating and distressing. 
It would be extremely valuable to gather much more information from patients’ pre- and 
post-cataract surgery experiences to understand the impact of PCO upon them. 
  








Material harvested post-mortem from cadavers provides an invaluable resource for the 
understanding of PCO morphology and identification of which molecules are present within 
the capsular bag as PCO progresses. Such molecules could be matrix components, cellular 
markers or growth factors. General features within the capsular bag of post-mortem 
specimens are often investigated using the Miyake-Apple method. This provides a posterior 
view of the capsular bag (Apple et al., 2001; Pereira t al., 2009). Techniques used to analyse 
post-mortem capsular bags include electron microscopy (Kappelhof et al., 1987; Marcantonio 
et al., 2000), immunochemistry (Marcantonio et al.,2000; Saika et al., 2002; Saika et al., 
2000; Wormstone et al., 2002), Real-time polymerase chain reaction (qRT-PCR) (Wormstone 
et al., 2001; Wunderlich et al., 2000) and Enzyme-linked Immunosorbent Assay (ELISA) 
(Wormstone et al., 2001; Wormstone et al., 2002; Wormstone et al., 2000). While this type of 
investigation provides “scene of the crime” information it does not provide definitive proof 
that various molecular suspects are responsible for PCO development. This information does 
however, create a blueprint of clinical outcomes,which experimental models should try to 
emulate. 
 
2.4. Cell culture 
Cell culture is the simplest method and the most comm n entry point into PCO research. This 
usually takes the form of primary cultures or cell lines. Although valuable, there are a number 
of difficulties in working with primary cultures (Wormstone and Eldred, 2016). In general, 
primary lens cells have limited longevity in culture and generally only survive for a few 
passages before they attempt differentiation or senesce, preventing long-term experiments 
and substantial data acquisition. One exception seem  to be the chick lens, which has been 
used to establish dissociated cell–derived monolayer cultures of primary embryonic chick 









investigate fibrotic and regenerative PCO (Boswell et al., 2017).   In general, lens cell lines 
are more readily used than primary cultures. In the lens field, the three main lines used are 
HLE-B3 (Makley et al., 2015), SRA01\04 (Ibaraki et al., 1998; Weatherbee et al., 2019) and 
FHL124 (Dawes et al., 2007b; Reddan et al., 1999; Wormstone et al., 2004). They are all 
derived from foetal or neonate lenses. HLE-B3 and SRA01\04 were generated using viral 
immortalisation methods. FHL124 in contrast is a non-virally transformed cell line.   Cell 
lines allow the study of PCO-related features that include migration, proliferation, matrix 
modification, matrix contraction and to a limited degree differentiation. It should be noted 
that cell lines demonstrate some level of transdifferentiation to myofibroblasts. This can limit 
understanding of changes directly linked to surgery/injury. However, expression of 
myofibroblasts increase with appropriate stimuli e.g. transforming growth factor β (TGFβ) 
and thus the human lens cell lines are valuable model systems to understand myofibroblast 
formation and fibrotic events.  Moreover, they are readily available and amenable to 
molecular manipulation. As a result, cell line cultures are a workhorse to enable elucidation 
of the mechanisms governing human lens cell biology. However, the value of such work is 
greater when used in combination with more sophisticated experimental systems, such as in 
vivo animals and the capsular bag model. 
 
 
2.5. In vivo animal models 
Animal models for PCO have utilised mouse and rat rodent systems and rabbit (Aliancy et 
al., 2018; Jo et al., 2014; Lois et al., 2003; Lois et al., 2005; Mamuya et al., 2014; Shihan et 
al., 2020; Wormstone and Eldred, 2016). The argument for the use of in vivo animal models 
is that they provide full replication of post-surgical events and access to appropriate stimuli, 









that the inflammatory environment in these systems truly represents responses observed in 
human patients (Bito, 1984). Ongoing assessment of PCO progression in these systems is 
generally limited, with the majority of information obtained from detailed end-point 
examinations. Another note of caution that is applicable to any animal-based experimental 
system relates to differential expression of proteins within the lens. For example, receptor 
profiles can be quite different between species (Wormstone et al., 2006b). This discordance 
can hamper true discovery of the underlying mechanisms driving PCO in patients, but also 
poses complications when assessing the potential of pharmacological agents to treat PCO. 
When using animal systems it is therefore important o cross-reference findings with human 
data (when available) to ensure the findings from an animal system are relevant and can 
provide maximum benefit to the field. 
 
Both the rat and mouse are commonly used experimental models. Due to the relative size of 
their lenses to humans, they cannot house a typical IOL. Nevertheless, models that allow 
investigation of PCO progression or PCO-like events are available. With respect to the rat, 
Lois et al (Lois et al., 2003) established a model that presented many of the characteristics of 
PCO seen in patients. These included cell growth on the central posterior capsule, 
fibroblastic-like cells with a spindle-shaped morphology and wrinkling of the capsule. 
Furthermore, Soemmerring’s ring was observed, demonstrating that lens fibre differentiation 
had occurred. Despite the successful demonstration of the rat model, this approach is rarely 
used. In general, the mouse is the most commonly utilised in vivo system to investigate 
mechanisms of PCO. This is largely because the excell nt genetic understanding of mice 
allows mechanistic testing in vivo using robust tools available for genetic manipulation. The 
ability to regulate gene and protein expression of specific targets is a valuable tool that 









et al., 2014; Shihan et al., 2020). Some groups have induced injury by performing a puncture 
wound in the anterior capsule (Saika et al., 2001), while others have created a linear tear of 
the anterior capsule to enable fibre cell removal (C ll et al., 2004) . To aid fibre cell removal, 
pressure is applied to the eye cavity with forceps, which could cause additional trauma to the 
eye over generally applied clinical procedures in patients. Lois et al (Lois et al., 2005) 
advanced practice within the mouse model by performing simulated cataract surgery, which 
included continuous curvilinear capsulorhexis and lens fibre removal by hydroexpression. 
Using this approach, cell proliferation, migration, EMT and differentiation can be observed 
following surgery.  
 
The rabbit in vivo system is a commonly used model in PCO research. It is however, seldom 
used as an investigative tool to identify mechanisms driving PCO. However, it has been 
employed as a tool to understanding mammalian lens r generation (Gwon and Gruber, 2010). 
Generally, the rabbit is used to assess IOLs and their impact on PCO due to the comparable 
size of the rabbit and human lenses (Aliancy et al., 2018). This therefore requires less 
adaption from a standard cataract procedure to enabl  surgery on rabbits. As a consequence, 
surgical procedures used on rabbits have followed th  trends observed in the clinic, such that 
procedures initially employed a linear capsulorhexis with simple extracapsular extraction 
(Behar-Cohen et al., 1995), but now employ continuous curvilinear capsulorhexis with 
phacoemulsification to replicate modern surgical procedures (Leishman et al., 2012). This 
model allows assessment of cell regrowth, matrix modification, EMT and differentiation. The 
rabbit undergoes a profound inflammatory response, which is sustained for much longer than 
is typical in human patients (Davidson et al., 1998; Pande et al., 1996)). The scale of this 
response is believed to accelerate PCO. The timescale of PCO formation and its severity in 









   
2.6. Tissue culture models 
Tissue culture is a valuable tool to investigate PCO. This generally takes the form of lens 
epithelial explants (West-Mays et al., 2010) and capsular bag systems (Wormstone, 2020). In 
both cases the cells are maintained on their natural s bstrate, the lens capsule. 
 
Lens epithelial explants have been established using le ses from a variety of species. Early 
efforts centred on the chick, but the bulk of studies to date have been performed using the rat 
lens explant system (West-Mays et al., 2010). Using this system growth, EMT and 
differentiation have been observed and thus epithelial xplants are a tractable system for the 
study of PCO (Gordon-Thomson et al., 1998; Mansfield t al., 2004; McAvoy and 
Chamberlain, 1989). Explant cultures can also be establi hed from human lenses (Maidment 
et al., 2004; Shu and Lovicu, 2017; Smith et al., 2019; Weatherbee et al., 2019). To date, 
growth, EMT, increased matrix production and contraction have been studied, but 
differentiation is yet to be observed. In terms of securing the explants to a culture dish, this is 
achieved either through the use of pressure from forceps or entomological pins (7-10mm 
long), which reduces the potential for detachment from the culture dish. 
 
A further development on the explant system is the generation of capsular bag culture 
models. The aim here is to recapitulate the same spatial cell and tissue arrangement as 
observed clinically. Capsular bag models have several variants and have been utilised in a 
range of species including human (Liu et al., 1996; Nagamoto and Bissen-Miyajima, 1994; 
Wormstone et al., 1997), bovine (Saxby et al., 1998), canine (Davidson et al., 2000), rabbit 










The majority of work using capsular bag models has used human donor tissue. A simulated 
cataract surgery is performed on donor eyes. In most ca es, the cornea is removed for 
transplant purposes and to aid visibility, the iris is removed. A continuous curvilinear 
capsulorhexis creates an opening in the anterior capsule that enables removal of the fibre 
mass by hydroexpression or phacoemulsification. Remaining fibre material is removed by 
irrigation/aspiration. As with surgery in a clinic, the product of this operation is a capsular 
bag. If required, an IOL can be implanted and studied. The capsular bag can be isolated from 
the eye by cutting the zonules and transferred to a dish for culture. This enables pure 
populations of cells to be maintained under controlled culture regimes and is ideal for 
addition/inhibition studies to define roles of specific candidates. If the capsular bag is 
isolated, it is important to maintain general circularity. To achieve this, ring systems and 
pinning have been used (Dawes et al., 2012; Liu et al., 1996; Saxby et al., 1998). It has been 
suggested that both methods can compromise the bag and have a greater influence on 
findings; the ring because of its bulk and pinning because it is perceived as an extra stress, 
however in relation to the trauma of surgery this is likely to be negligible. Nevertheless, this 
system has proved to be of great value and has contributed to many significant findings in the 
field. A variant of the capsular bag model is to retain the zonules and transfer the 
ciliary/zonules/lens complex to a ring support (Cleary et al., 2010; Eldred et al., 2014; Eldred 
et al., 2019). The ciliary body is pinned to the ring and the capsular bag suspended over the 
lumen. This approach combined with improvements in culture conditions that better reflect 
surgical inflammation, maintains the capsular bag integrity and is ideal for studying IOLs in 
relation to PCO (Eldred et al., 2014; Eldred et al., 2019; Hillenmayer et al., 2020) (Figure 2).   
 
After humans, the most common patients that undergo cataract surgery are canine. As with 









PCO. In fact, the incidence of PCO in canines is 100% and similar to the rates observed in 
very young children. Canine models for PCO and the capsular bag in particular have direct 
relevance to a patient group and offer valuable insight into human PCO. The canine capsular 
bag model first described by Davidson et al (Davidson et al., 2000) built on the human model 
described by Liu (Liu et al., 1996). The model has been used to good effect to better 
understand canine PCO and develop better ways of managing the condition (Chandler et al., 
2012) 
 
Menko et al developed a modification of both the explant and capsular bag culture systems in 
chick (Walker et al., 2007). This model again involves simulated surgery on the chick lens. 
Fibre cells are removed by hydroexpression following disruption of the anterior capsule by 
incision. Four ‘flaps’ of the anterior epithelium are established by radial cuts. These flaps are 
folded back and secured to the culture dish, such that the preparation resembles a star. This 
method exposes the entire PC and thus both central and peripheral regions of this surface can 
be easily studied. Using this system, migration andgrowth across the posterior capsule and 
EMT have been investigated. (Walker et al., 2007). A similar approach has also been applied 
to the human capsular bag system to create a fully open test system (Eldred et al., 2016).  
 
 
2.7. Stem cells 
Following cataract surgery, there is evidence to suggest that the lens makes efforts to 
regenerate. In order to do so, fibre cell formation via cell differentiation is required. While 
clinical work has demonstrated that lens regeneration - in infants at least - is possible using 
modified surgical approaches (Lin et al., 2016), in most cases this is imperfect; the outcome 









Understanding the process of human lens cell differentiation is therefore important in terms 
of understanding how best to regenerate a lens post-surgery. It may also help us to understand 
how Soemmerring’s ring and Elschnig’s Pearl formation is initiated and regulated. The 
ability to establish lens organoids or ‘lentoids’ from stem cells provides an excellent system 
to achieve this and in turn advance our understanding of regenerative PCO. 
  
The first method describing lentoid formation from human stem cells was published by Yang 
et al (Yang et al., 2010). This study used human embryonic stem cells (hESCs) and adopted a 
three-stage culture strategy that employed sequential i hibition and activation of Fibroblast 
growth factor (FGF), Transforming growth factor beta (TGFβ) and Wnt signalling to guide 
naïve stem cells to a three-dimensional lens-like organoid. In the first of the three stages, 
100ng/ml Noggin (a bone morphogenic protein (BMP) ligand inhibitor), was added to the 
culture medium for six days to direct the naïve hESCs towards a lens placode phenotype. 
This initiation was followed by Stage 2, comprising a period of 12 days wherein the Noggin 
was replaced by 20ng/ml BMP4, 20ng/ml BMP7 and 100ng/ml basic FGF in the medium to 
facilitate the instigation of fibre cell differentia on. For Stage 3, the cultures were exposed to 
20ng/ml Wnt3a and 100ng/ml basic FGF to encourage lens fibre cell maturation and 
elongation. During the early stages of culture, pluri otency markers NANOG and OCT3 were 
suppressed. Lens placode markers including Pax6, Sox2 and Six3 were up-regulated. Pax6 
peaked at day 10, but gene expression was maintained throughout culture. Signals for Sox2 
and Six3 both peaked at day 6 of culture and remained elevated at day 10, but were expressed 
at low levels beyond this time point. As the culture period extended, a progressive up-
regulation in lens fibre cell markers CRYAA, CRYBB2, CRYGC and MIP was detected 
using quantitative real-time PCR (qRT-PCR), indicating lens fibre cell maturation and lentoid 









formation of three-dimensional lentoid structures. Together, the morphological and molecular 
phenotype of the organoids generated was consistent with a human lens phenotype.   
 
Takahashi and Yamanaka (Takahashi and Yamanaka, 2006) made a significant breakthrough 
which demonstrated that induced pluripotent stem cells (iPSCs) could be generated directly 
from fibroblast cultures by the addition of Oct3/4, Sox2, c-Myc, and Klf4 (subsequently 
known as the ‘Yamanaka factors’). The use of these factors to re-programme somatic cells 
back to ‘stemness’ provides major advantages experimentally over the use of embryonic stem 
cells; it removes some ethical challenges associated with the use of hESCs and increases the 
scope and amount of material available for research. Fu et al (Fu et al., 2017) generated 
induced pluripotent stem cells (iPSCs) from clinically isolated human urinary cells. They 
then adapted the three-stage protocol described by Yang et al (2010): following Stage one, 
differentiating cells formed structures that resembled fried eggs. They selected specific 
portions of the ‘fried eggs’ and transferred them to new culture vessels for continued culture 
in Stage 2 and 3 culture conditions. This adaption o the protocol aimed to select cells that 
were primed for lentoid formation, ultimately to increase the efficiency of the process and the 
lentoid yield. Changes in molecular markers followed a similar pattern to Yang et al (2010). 
The lentoids formed were relatively transparent andrefractive. This study also provided 
ultrastucture detail of the lentoids.  
 
Further adaptions to the established protocol were r ported by Murphy et al (Murphy et al., 
2018). In Stage 1, Noggin concentration was increased from 100ng/ml to 500 ng/ml; 
additionally, 10 nM SB431542, an Alk5 inhibitor, was dded to the culture medium. In Stage 
3 the FGF2 concentration was reduced from 100ng/ml to10 ng/ml. A major feature of this 









tool for lens purification during Stage 2 of the lentoid differentiation protocol using magnetic 
activated cell sorting (MACS). Following ROR1+ selection, cells were plated on Matrigel-
coated dishes in M199 medium (Thermo Fisher Scientif c) containing 10 ng/ml of FGF2. The 
mini lenses/lentoids generated using this protocol were shown to have some level of 
transparency and focussing power. 
 
The work described above has made outstanding contributions to the field and has laid the 
foundation for future research. However, there is always scope for improvement and 
refinement. Here we present another advance that overc mes an unwanted variable associated 
with stem cell research.  
 
A common feature of the protocols described above is the use of mouse sarcoma-derived 
Matrigel as a culture substrate (Fu et al., 2017; Murphy et al., 2018; Yang et al., 2010).  
Unfortunately, the composition of Matrigel varies batch-to-batch because it contains variable 
quantities of growth factors such as Transforming Growth Factor β (TGFβ) and Platelet-
Derived Growth Factor (PDGF) that are commonly controlled and manipulated in 
developmental experiments. This inconsistency could influence the physiological outcomes 
of developmental experiments due to the Matrigel-derived growth factors contributing to the 
experimental conditions in undefined, variable ratios. We therefore aimed to generate 
lentoids from iPSCs using a defined replacement for Matrigel that was of standardised origin, 
thus moving the current protocol towards a better-defined system using fewer animal-derived 
components. We selected iMatrix-511 as our culture substrate, which is composed of 
recombinant human laminin 511-E8 fragments. iPSCs (ellartis ChiPSC22) were seeded 
onto iMatrix obtained from Takara Bio (Cat. No T303) and subjected to the three-stage 








treating the cells in supplemented mTeSR1 (Stemcell Cat. No 85850) with the addition of 
specific growth factors at different stages:  Stage 1) addition of 100 ng/ml Noggin from day 0 
to 6, Stage 2) combination of 100 ng/ml bFGF, 20 ng/ml BMP4 and 20 ng/ml BMP7 from 
day 6 to 18, Stage 3) combination of 100 ng/ml FGF2 and 20 ng/ml Wnt-3a from day 18 
onwards. Cells were seeded at a density of 10,000 cells per cm2 and cultured in a humidified 
environment at 35oC with 5% CO2. Animal-free growth factors were used where available, 
thus moving the system towards a fully-humanised, xno-free model representative of human 
development. Cultures were observed using a Nikon Eclipse Ti2 inverted light microscope 
and growth medium was changed every other day. Growth factors were obtained from 
Miltenyi Biotech and Peprotech and were prepared and stored according to the 
manufacturer’s instructions. In order to validate th  progression of iPSCs to lentoids, we 
chose to examine a set of genes using quantitative real-time PCR. The genes analysed were 
selected to best capture different stages of lens development. OCT4 was selected as a 
pluripotency marker; SSEA1 as a marker of differentiation; Pax6 as a marker of ‘eye lineage’ 
specification; PitX3 as a marker of fibre induction a d lens maturation; αA-crystallin 
(CRYAA) as an indicator of crystallin accumulation in developing lentoids; FOXE3 as an 
indicator of lens cells; MIP/Aquaporin 0 to demonstrate the presence of mature fibre cells; 
and crystallins beta-2 (CRYBB2), and gamma-D (CRYGD) as markers of further maturation 
towards lens phenotype.  
 
Following Stage 1 culture the cells formed a collection of distinct single-layer clusters 
(Figure 3A). Stage 2 culture induced progressive organisational changes that gave rise to 
structures resembling ‘fried eggs’ (Figure 3A), as fir t reported by Fu et al (Fu et al., 2017). 
These structures developed to form three-dimensional structures that possessed some 








throughout Stage 2 culture to produce lentoids thatwere more consistent in form with a 
smooth surface and were clear and refractive in nature (Figure 3A). Stage 3 culture 
conditions seemed to merely continue this progression. 
 
Gene expression analysis (Figure 3B) by qRT-PCR of RNA isolated from the cultures at 
specific time-points (Days 0, 6, 12 and 18) revealed that OCT4 decreased progressively over 
the course of the experiment, indicating loss of pluri otency of the cells; SSEA1 increased 
over the same time period, indicating differentiation of the cell population. Pax6 - the master 
‘eye’ gene was strongly expressed from day 6 onwards. Pax6 peaked at day 12 then declined, 
indicating its role in defining an ocular cell phenotype. Key lens cell markers FOXE3 and 
αA-crystallin were significantly elevated at day 18 and in the case of αA-crystallin, levels 
were 32.65 ± 12.33-fold higher than day zero samples. This enrichment in αA-crystallin 
indicates the initiation and development of fibre cll differentiation, which is further 
supported by elevation of the lens markers PitX3 and crystallin beta-2 at the day 18 time-
point. Gene expression of the mature fibre cell markers gamma-D crystallin and MIP was 
also elevated at day 18.  
 
In summary, we have progressed the current methodology for differentiation of human iPSCs 
into maturing lentoids. We adapted the previously-cited protocol by using iMatrix to replace 
Matrigel, thus reducing growth matrix-associated variability and removing one animal-
derived component from the system. Despite this change, we achieved the same results as 
other groups who have employed this differentiation method, proving that our innovation is 
not detrimental to the overall process. With furthe refinement, we hope to use this method to 









formation of Soemmerring’s ring and Elschnig’s Pearls. This could help us gain new insights 
into the mechanisms that underpin regenerative PCO. 
 
3.  The biological regulation of PCO 
Having introduced the range of experimental tools avail ble for PCO research, we will now 
discuss the regulatory processes that govern PCO progression (Figure 4). To aid this 
discussion, we will describe the two major forms of PCO in relation to specific events and in 
order of involvement post-surgery. Fibrotic PCO is initiated by surgical injury, occurring in 
all patients to some degree. Fibrotic PCO follows classically defined fibrotic processes, 
namely hyper proliferation, matrix contraction, matrix deposition and cell transdifferentiation 
from an epithelial to myofibroblast phenotype (Eldre  et al., 2011; Leask and Abraham, 
2004). Regenerative PCO is characterised by lens fibre cell differentiation that gives rise to 
Soemmerring’s ring and Elschnig’s pearls and becomes evident at a later stage than the 
fibrotic form. Both fibrotic and regenerative forms of PCO contribute to a reduction in visual 
quality in patients, however it is reported that the regenerative form has a greater impact due 
to the refractive properties of Elschnig’s pearls (van Bree et al., 2011).  
 
3.1. Fibrotic PCO 
In order to appreciate the changes that take place following cataract surgery that ultimately 
lead to posterior capsule opacification, it is important to appreciate the lens and its natural 
environment prior to surgery. The lens is an unusual tissue as it does not contain any blood 
vessels or nerves and gains all nutrients from the surrounding humours (Wormstone and 
Wride, 2011). It is a remarkable feat of biological engineering that the lens is capable of 
maintaining transparency for so long. It could be argued that the lens has developed a sense 









to manufacture proteins to aid cell survival and organ function. Indeed the bulk of survival 
factors, including transferrin, detected in the aqueous humour are produced by the lens 
(McGahan et al., 1995). Gene and protein expression patterns are well governed across the 
lens epithelium and fibre cell populations (Hawse et al., 2005; Hodgkinson et al., 2007; 
Maidment et al., 2004). However, disruption to the ey  and perturbation of the lens through 
mechanical injury provokes significant change to the ocular environment, lens cells and the 
capsular matrix on which they reside (Figure 4).  
 
The first objective of lens cells in the face of surgical insult is to survive. If the supply of 
growth and survival signals is insufficient, this will lead to cell death, presumably by 
apoptosis (Ishizaki et al., 1993). The intrinsic ability of lens cells to self-regulate their activity 
in what is naturally a harsh environment is likely to contribute to the long-term development 
of PCO. Human capsular bag studies have remarkably demonstrated that lens cells can 
survive in serum-free medium for over 1 year (Wormstone et al., 1997). Ishizaki et al 
(Ishizaki et al., 1993), in a study using rat lens cells, found that the underlying matrix and cell 
density were the major factors that enable lens cell  to survive in a protein-free medium and 
avoid undergoing cell death by apoptosis. It has also been shown that human capsular bag 
cultures maintained in serum-free medium can releas a number of cytokines and growth 
factors following cataract surgery, including interleukins, FGF and VEGF (Dawes et al., 
2013; Eldred et al., 2016). A number of these factors play a role in proliferation, migration 
and cell transdifferentiation. A similar pattern of cytokine expression is also observed with 
the in vivo mouse model (Jiang et al., 2018).While endogenous production of PCO-
promoting factors will undoubtedly play a long-term ole in PCO formation, the influence of 











Following cataract surgery, there is a marked up-regulation of proteins within the aqueous 
humour. This is associated with an inflammatory respon e; coincidentally, fibrotic disorders 
are also often associated with inflammatory responses. The ultimate objective of an 
inflammatory response is to facilitate repair of the damaged tissue. Chemicals released from 
damaged tissue attract white blood cells, including lymphocyte T helper cells, which 
coordinate an immune response by releasing cytokines such as interleukins. These secreted 
proteins activate resident macrophages that further enhance the production of cytokines, 
chemokines and other inflammatory mediators as wellas recruiting monocytes (Martinez et 
al., 2006), which can accelerate PCO development.  
 
As surgical procedures have advanced to become less disruptive, a marked benefit has been 
the reduction in inflammatory response (Pande et al., 1996). The introduction of foldable 
lenses in conjunction with phacoemulsification to remove the fibre mass rather than 
hydroexpression is less traumatic to the eye due to the smaller incision required for this 
procedure. Interestingly, it has been shown in the capsular bag model that the method of fibre 
mass removal does not affect lens cell population or gr wth responses under comparable 
conditions (Quinlan et al., 1997), therefore potential reductions in PCO are likely to result 
from reduced inflammation. Assessment of protein flare in the aqueous humour following 
cataract surgery indicates a spike followed by a gradual return to baseline in a few weeks 
(Pande et al., 1996). The same general pattern was seen with phacoemulsification and 
hydroexpression cataract extraction methods; however, th  scale of response was more severe 









Breaching the blood aqueous barrier permits a number of blood proteins to enter the ocular 
environment, which can further enrich the local concentrations of cytokines and growth 
factors. These factors can directly stimulate lens cells or interact with the lens capsule, which 
can provide a long-term reservoir of molecules thatcan advance PCO over months and years 
(Wormstone et al., 2006a). A number of growth factors such as FGF, Epidermal growth 
factor (EGF), vascular endothelial growth factor (VEGF), interleukins and thrombin can 
promote survival, proliferation and migration (Eldre  et al., 2016; Wormstone et al., 2001; 
Wormstone et al., 2004; Wormstone et al., 2000). Transforming growth factor β (TGFβ) is 
also elevated in the eye following surgery. TGFβ does not appear to be a key promoter of 
human lens cell growth (Wormstone et al., 2002; Wormstone et al., 2004) but is believed to 
play a critical role in many fibrotic events (Leask and Abraham, 2004). TGFβ is elevated in 
the eye to regulate the severity of inflammatory response through suppressing the actions of 
white blood cells (Streilein et al., 2002). This function of TGFβ affords overall protection to 
the eye, but active TGFβ enrichment of the aqueous humour can stimulate lens cells and 
drive fibrotic PCO.  
 
A number of patients undergoing cataract surgery have uveitis, a chronic inflammation of the 
eye (Ozates et al., 2020). It has been reported that patients experiencing idiopathic anterior 
uveitis have higher levels of interleukins (IL), monocyte chemoattractant protein-1 (MCP-1) 
and interferon gamma (IFNγ) in the aqueous humour. It is therefore likely that c taract 
patients with uveitis will have a more severe and sustained inflammatory response that is 
likely to accelerate PCO progression (Ozates et al., 2020).  
 









Proliferation, in association with migration, is animportant aspect of wound healing and 
PCO. Some interesting data have been reported using the BrdU labelling and detection 
technique to identify dividing cells (Rakic et al., 1997; Wormstone et al., 1997; Rakic et al., 
2000). In one study (Rakic et al., 1997), it was shown that simply performing a small 
capsulorhexis could up-regulate the rate of division in the lens relative to the unperturbed 
lens. Moreover, if the fibre cells were removed, the rate of cell division was stimulated even 
more. These experiments were repeated by Lin et al (Lin et al., 2016) who also reported an 
11-fold increase in BrdU positive cells within the uman capsular bag following fibre cell 
removal. Analysis of capsular bags following 3 days culture in serum-free medium showed 
increased numbers of BrdU positive cells (Wormstone et al., 1997). The distribution of these 
positive cells was predominately in the equatorial region, the natural site of division, however 
some cells were observed on the anterior capsule. Frthermore, if the capsular bags from 
aged donors (>60 years) were established in the presenc  of serum, then the dividing 
population was increased, but the distribution pattern remained the same. It is notable that 
lens cells growing on capsular bags maintained in serum-free medium from a wide age 
spectrum can effectively colonise the entire surface of the once cell-free posterior capsule. 
However, as expected, growth occurs at a greater rat  in capsular bags from younger human 
donors than older donors (Wormstone et al., 1997). Supplementing the medium with 10% 
FCS dramatically increased the rate of cell growth on aged capsular bags (>60 years), but did 
not greatly enhance the cell growth rates on their younger (<40 years) counterparts 
(Wormstone et al., 1997; Wormstone et al., 1997). These data also reflect the increased 
requirement for secondary surgery to treat PCO in young patients (Moisseiev et al., 1989; 
Knight-Nanan et al., 1996). Furthermore, the findings suggest that powerful autocrine 
mechanisms in the young are active following surgical trauma. A number of growth factors 









(McAvoy and Chamberlain, 1989; Wormstone et al., 2001), hepatocyte growth factor (HGF) 
(Choi et al., 2004; Wormstone et al., 2000), EGF (Hongo et al., 1993; Ibaraki et al., 1995; 
Majima, 1995) (Maidment et al., 2004; Wertheimer et al., 2015b), Thrombin (James et al., 
2005), Wnt (Bao et al., 2012), interleukins (Dawes et al., 2013; Eldred et al., 2016) and 
VEGF (Eldred et al., 2016).  
 
An interesting study employing young (<40 years) and ged (>60 years) capsular bag cultures 
assessed the levels of growth factors secreted into the medium within the first 2 days post-
surgery and found significant decreases in IL-1β and IL-6 in the >60 years group (Dawes et 
al., 2013). In contrast, IL-10, IL-12, IL-13, and VEGF in the >60 years group were 
significantly increased compared with their younger counterparts. Capsular bags (cells and 
capsule) were also analysed and it was found that preparations from > 60year old donors had 
greater than or equal levels of FGF and HGF compared to their younger counterparts. In 
addition, aged capsular bags also presented higher rates of protein synthesis. This suggested 
that the established age-dependent differences in cell growth observed were not resulting 
from limited availability of growth factors. Attention then centred on signalling pathways. 
Inhibition of ERK, p38, and JNK signalling using specific inhibitors significantly suppressed 
cell coverage on the posterior capsule demonstrating the relative importance of each pathway. 
The activity status of these pathways was assessed by detection of pERK, p-c-jun, p-p38, and 
pJNK.  A consistent pattern emerged such that phosphorylated signalling molecules were 
lower in aged cell populations; total signalling protein expression was unaffected by age. It 
would therefore seem that availability of stimulating factors is not a limiting factor as we age, 
but the ability to convert this resource into signalli g activity is, which is likely to impede the 










A question that is often asked relates to the origin of cells leading to posterior capsule 
opacification.  This is difficult to discern using in vivo models or clinical observation as the 
peripheral capsular bag is obscured. Information ca, however, be extracted from capsular 
bag studies that provide some insight. When pinned to a dish, in the absence of an IOL, the 
anterior and posterior capsules of the capsular bag naturally lie on top of one another. In this 
configuration, cells start to colonise the central posterior capsule within the rhexis margin 
within the first week of culture (Eldred et al., 2016). When suspended cultures are established 
with an IOL implanted, the capsules do not initially form a close connection. With this 
arrangement, cell growth is observed on the posterior capsule and takes more than one week 
to reach the central posterior capsule (Eldred et al., 2019). This would suggest that equatorial 
cells can proliferate and migrate across the posteri r capsule, but if the capsules come into 
close apposition, anterior epithelial cells can relocate to the posterior capsule and contribute 
to the coverage of the posterior capsule.  
 
3.1.2. Transforming growth factor β signalling 
While arguably not a potent driver of lens cell growth, TGFβ is strongly implicated in fibrotic 
responses (Leask and Abraham, 2004). The major isoform synthesised within the eye is 
TGFβ2, although TGFβ1 and 3 can also reach the aqueous humour from the blood (Ohta et 
al., 2000; Schlotzer-Schrehardt et al., 2001). Post-mortem analysis of a capsular bag received 
from a donor one month following cataract surgery demonstrated increased levels of αSMA, 
a marker of myofibroblasts, and matrix contraction/wrinkling of the posterior capsule 
(Wormstone et al., 2002).  This does not provide dir ct evidence that TGFβ can induce these 
changes, but many of these features are linked to TGFβ and fibrosis. A large body of 
evidence demonstrates the ability of active TGFβ to promote cellular responses that define 









extracellular matrix production and deposition and matrix contraction (Eldred et al., 2011) 
(Figure 5).  
 
In order to signal, active TGFβ binds to the extracellular domain of TGFβ receptor II 
(TGFβRII) dimer, which are autophosphorylated serine/thronine kinase receptors 
(Massague, 2012).  A TGFβ receptor I (TGFβRI) dimer is recruited to form a hetero-
tetrameric receptor complex with the TGFβ ligand. Due to conformational changes, TGFβRII 
transphosphorylates serine and threonine residues on the intracellular domain of TGFβRI. 
Activated TGFβRI can then regulate a number of signalling pathways. The best defined is the 
Smad signalling pathway, but Smad-independent pathways are also recognised and believed 
to play important roles in lens cell regulation (Derynck and Zhang, 2003).   
 
A prerequisite for TGFβ involvement in the fibrotic response is availability. TGFβ is present 
in the aqueous humour of the eye: this is largely in a latent, inactive form (Ohta et al., 2000; 
Schlotzer-Schrehardt et al., 2001). The latent form f TGFβ is converted to the active form by 
proteolytic cleavage of pro-segments. In the normal eye, levels of active TGFβ are of low 
abundance and its activity can be further controlled by scavenger proteins in the ocular 
humours, for example α2-macroglobulin (Schulz et al., 1996). Mechanical injury resulting 
from surgery can significantly increase the abundance of active levels of TGFβ  through 
increased production of TGFβ2 and influx of blood protein in concert with elevated 
proteases, such as plasmins, cathepsins and MMPs (Yu and Stamenkovic, 2000), which 
cleave latent TGFβ precursor protein.  In addition, elevated numbers of reactive oxygen 










Analysis of post-mortem material provides evidence-linking TGFβ2 to PCO. Saika et al 
(Saika et al., 2002) analysed a number of post-mortem capsular bags obtained months and 
years following surgery to identify if active TGFβ signalling was evident. Samples examined 
for expression and distribution of Smad3 and Smad4, which are key proteins in the 
established TGFβ/Smad signalling pathway. Within this pathway, Smad2 and 3 are 
transcription factors, which are phosphorylated by ligand-activated TGFβRI. Both Smad2 
and 3 have a high affinity for Smad4 and form a complex with it. This complex translocates 
to the nucleus allowing Smad2/3 to engage with co-activ tors or repressors and regulate gene 
transcription. All the post-mortem samples demonstrated Smad2/3 staining in the nuclei, 
which indicates an active signalling pathway (Saika et l., 2001). Interestingly, this study also 
examined Smad3 and 4 in native human lens tissue. In these preparations, Smad3 and 4 were 
distributed in the cytosol, with no evidence of translocation to the nucleus. A reason for this 
could be a low abundance of TGFβ receptors. If either of the receptors is lacking, li and-
induced signalling will be impaired. This also tallies well with a study of human lens 
cultures, which showed an inability of cultured human lenses to form fibrotic plaques (a 
feature of anterior subcapsular cataract, a lens coditi n that relates to PCO), unless they 
were severely challenged by chemical or mechanical injury (Marcantonio et al., 2003). 
Interestingly, TGFβ can induce anterior subcapsular cataract in a rat lens culture model  
(Hales et al., 1994) and in animals with a TGFβ overexpression system (Banh et al., 2006) 
implying differences in sensitivity and the natural configuration of TGFβ signalling between 
species. Work in our laboratory has utilised human le s epithelium to further test the 
sensitivity to TGFβ following injury. To isolate anterior lens epithelium the lens was first 
placed with the anterior surface down on a culture dish. A puncture was made in the posterior 
capsule and four radial incisions made towards the equator. The fibre mass was carefully 









a series of linear capsulorhexes. Each quarter was tran ferred to a separate culture dish and 
maintained in serum-free EMEM for 0, 6, 24 or 48 hours following dissection. Previous work 
has shown that a 2 hour exposure of human lens cellto 10ng/ml TGFβ will produce peak 
translocation of Smad2/3 to the nucleus, if a functio ing TGFβ/Smad signalling pathway is 
present (Dawes et al., 2007a). Therefore, to assess when TGFβ/Smad signalling was active 
we exposed the cultured epithelium to 10ng/ml TGFβ for the final two hours of culture. At 
each respective endpoint, preparations were fixed for 30 mins in 4% formaldehyde. Smad2/3 
visualisation was achieved using immunofluorescence methods and viewed with a Zeiss 
Axiovision fluorescence microscope. The data showed that the epithelium was unresponsive 
to TGFβ2 following 6 hours of culture, but exhibited Smad signalling in some cells at 24 
hours while at 48 hours the majority of cells were actively signalling (Figure 6). This data 
shows that mechanical injury moves lens epithelial cells from being relatively unresponsive 
to TGFβ to being highly sensitive. TGFβ levels are likely to remain elevated in the ocular 
environment for days or weeks following surgery with adsorption of TGFβ to the lens 
capsule a likely source for long-term activity (Wormstone et al., 2006a). Therefore, once lens 
cells establish a receptor signalling apparatus, TGFβ is readily available to stimulate TGFβR-
mediated signalling, which can induce long-lived fibrotic responses through Smad-dependent 
and Smad-independent signalling. 
 
Smad signalling is the best-defined TGFβ signalling pathway and has been well studied in 
lens fibrotic disorders (Banh et al., 2006; Dawes et al., 2009; Saika et al., 2004; Saika et al., 
2002). Experiments using murine lenses demonstrated increased myofibroblast expression in 
response to a puncture injury (Saika et al., 2001). If these animals received TGFβ neutralizing 
antibodies prior to puncture wound injury, Smad3 and 4 translocation to the nucleus was 









demonstrated using Smad3 knockout transgenic mice (Banh et al., 2006; Saika et al., 2004). 
Saika et al (Saika et al., 2004) reported that both TGFβ2-induced and injury-induced αSMA 
expression was inhibited in the lens epithelium of Smad3-knockout mice relative to wild 
type. Loss of Smad3 in mice also reduces the expression of trauma-induced type I collagen in 
the lens (Saika et al., 2004). A similar study was also performed on Smad3 knockout mice, 
which again used a puncture wound to the anterior epith lium and confirmed that Smad3 was 
required for expression of many fibrotic markers including myofibroblast markers such as 
αSMA (Meng et al., 2018). In addition, a Smad3 inhibitor, SIS3 suppressed TGFβ-induced 
expression of fibrotic markers in HLEB3 cells, suggesting an important role in a human 
model (Meng et al., 2018). Application of the same inhibitor also suppressed TGFβ-induced 
expression of myofibroblast markers in rat lens explants (Taiyab et al., 2019). In order to 
theoretically suppress the Smad signalling pathway, siRNA was used to prevent Smad4 
expression in FHL124 cells (Dawes et al., 2009). Smad4 knockdown prevented TGFβ-
induced αSMA and fibronectin expression, which suggests that TGFβ Smad3-Smad4 
signalling is likely to control transdifferentiation of human lens epithelial cells. Curiously, 
this study found TGFβ-induced matrix contraction and Smad7 expression to be independent 
of Smad4 expression; suggesting that TGFβ-Smad independent pathways may also regulate 
lens fibrosis.  
 
In addition to Smad-signalling, it has become increasingly apparent that TGFβ receptor 
activation can regulate a number of Smad-independent sig alling pathways (Derynck and 
Zhang, 2003). Such pathways include Ras-Raf-MEK-ERK mitogen-activated protein kinase 
(MAPK) (Lee et al., 2007), the p38 MAPK pathway (Galliher and Schiemann, 2007), the 
JNK MAP kinase and Rho kinase signalling pathways (Moustakas and Heldin, 2009) and 








Borok, 2007). The first demonstration that TGFβ could activate Smad-independent signalling 
pathways in lens cells was performed on FHL124 cells and showed that ERK and p38 MAP 
kinase signalling pathways were stimulated (Dawes et al., 2009). As FHL124 cells still 
promote matrix contraction in the absence of Smad signalling it is likely that matrix 
contraction is regulated by Smad-independent pathways. It is possible that the ERK MAPK 
signalling pathway could play a role in matrix contrac ion in PCO through its reported 
activation of myosin light chain kinase (MLCK), a key enzymatic regulator of contractile 
force (Klemke et al., 1997). It has been demonstrated that ERK1/2 signalling was activated in 
TGFβ2-induced EMT in the human lens cell line SRA01\04.  Application of the 
MEK/ERK1/2 inhibitor, U0126, prevented the TGFβ2-induced upregulation of fibrotic 
markers, α-SMA, collagen type I, collagen type IV and fibronectin (Chen et al., 2014). 
Studies using the rat lens explant model also report that ERK activation is required for the 
initiation of TGFβ-induced EMT, but not its progression (Wojciechowski et al., 2017). 
Further investigations using the rat explant system have demonstrated that TGFβ treatment 
results in activation of Rho/ROCK and β-catenin/cyclic AMP-responsive-element-binding 
protein (CREB)–binding protein (CBP) signalling pathways; inhibition of either result in 
prevention of TGFβ-induced EMT in the lens (Korol et al., 2016; Taiyab et al., 2019; Taiyab 
et al., 2016). (Taiyib 2019; Taiyib  2016; Korol 2016).   In addition, the p38 MAPK pathway 
has been found in chick lens cells to play a key role in TGFβ-induced transdifferentiation of 
epithelial cells to myofibroblasts through suppression of the pathway using the p38 specific 
inhibitor SB20358 (Boswell et al., 2017).  
 
There is no doubt that TGFβ can induce both transdifferentiation of lens epithel al cells to 
myofibroblasts and promote matrix contraction. It is a common view that these two processes 








synthesis and contraction in fibrosis (Shu and Lovicu, 2017). Contraction of the extracellular 
matrix of the lens capsule is a key aspect of PCO as wrinkling of the capsule resulting from 
contraction can cause light scatter (van Bree et al., 2011). Human lens cell lines have been 
utilised to allow detailed investigations of the signalling pathways regulating fibrotic events 
in the lens. Using this experimental tool, assays have been developed to determine matrix 
production, transdifferentiation and matrix contracion (Dawes et al., 2008; Dawes et al., 
2009; Wormstone et al., 2004). These studies suggest TGFβ regulates transdifferentiation and 
matrix contraction through independent pathways. The first indication to support this idea 
resulted from comparative studies of TGFβ1 and TGFβ2 using FHL124 cells (Dawes et al., 
2008). This study suggested that TGFβ1 was a more potent inducer of matrix contraction than 
TGFβ2. In contrast, TGFβ2 was better able to induce αSMA expression. This triggered a 
series of inhibition studies to understand the pathw ys regulating TGFβ-induced fibrosis. 
Their findings revealed that αSMA expression and fibronectin/fibronectin receptors a e not 
essential for TGFβ-induced matrix contraction to occur (Dawes et al., 2008).   
 
Together these findings demonstrate that TGFβ regulates a number of signalling pathways 
that are capable of interacting to create a signalling network. Careful dissemination of 
signalling pathway interplay will help further unravel the intimate role TGFβ plays in PCO 
formation. 
 
3.1.2.1. Additional regulators/promoters of TGFβ signalling 
 
While evidence is strong to support a role for TGFβ in fibrotic PCO formation, it is important 
to note that other factors can play critical support r les or could promote fibrotic events 
directly. For example, work carried out on the rat lens explant model has demonstrated that 









In addition, treatment of explants with PD153035, an EGFR inhibitor, suppressed TGFβ-
induced changes. It is important to note that EGF alone does not induce any fibrotic response 
(Shu and Lovicu, 2019). Basic FGF, Wnt, VEGF and CTGF have also been reported to 
mediate or amplify fibrotic responses (Cerra et al., 2003; Kubo et al., 2018; Ma et al., 2014; 
Mansfield et al., 2004; Taiyab et al., 2016). Recently, Gremlin has emerged as a potentially 
important pro-fibrotic molecule in PCO formation. Gremlin plays a role in a number of 
fibrotic conditions. Gremlin expression is significantly elevated in lens epithelial cells 
following cataract surgery on mice (Shihan et al., 2020). In a FN knockout mouse, gremlin 
levels were lower than wild type and this correlated with a reduced fibrotic response (Shihan 
et al., 2020). Exogenous administration of gremlin or TGFβ1 in FN knockout animals was 
able to restore the fibrotic response (Shihan et al., 2020). A study using a rat in vivo model 
also reports that gremlin inhibition is associated with reduced PCO scores (Ma et al., 2019).  
In general, pro-fibrotic actions of gremlin arise from inhibition of BMP signalling. BMP4 and 
7 in particular are known to be anti-fibrotic. The ability of Gremlin to suppress BMP4 and 7 
signalling is observed with HLE-B3 cells. Interestingly, addition of gremlin to HLE-B3 cells 
lead to increased αSMA, fibronectin and collagen I expression (Ma et al., 2019). In addition, 
200µg/ml gremlin increased phosphorylation of Smad2 nd 3 in a timeframe comparable to 
TGFβ (Ma et al., 2019), which supports the idea that gremlin can directly trigger TGFβ/Smad 
signalling (Sethi et al., 2011). In addition, Gremlin can also promote ERK and Akt signalling 
pathways (Ma et al., 2014). 
 
A further cellular product that could contribute to TGFβ mediated fibrosis are reactive 
oxygen species. Using rat explants and whole lens cultures treatment with antioxidants could 
prevent TGFβ induced fibrosis (Chamberlain et al., 2009). In addition, work on mice has 
shown that glutathione depletion can upregulate EMT pathways (Wei et al., 2017; Whitson et 









role for NOX4 in this process was proposed. NOX4 is elevated in FHL124 cells and rat 
explants by TGFβ (Das et al., 2016; Dawes et al., 2007b). Inhibition f NOX4 using 
VAS2870 suppressed TGFβ-induced fibrosis (Das et al., 2016). This was furthe  investigated 
using NOX4 deficient mice (Das et al., 2020). These animals demonstrated a delay in fibrotic 
plaque formation with TGFβ over-expression compared to wild type. Fibrosis wa therefore 
impaired, but not ablated with upregulation of NOX2 proposed as a compensatory 
mechanism (Das et al., 2020). 
 
3.1.3. Extracellular matrix involvement and regulation 
Extracellular matrix (ECM) plays a key role in the regulation of cell behaviour and increased 
synthesis and deposition of ECM proteins is a fundamental feature in the pathogenesis of 
fibrotic disorders (Leask and Abraham, 2004). The lens capsule is largely composed of 
collagen IV, along with laminin, heparin sulphate proteoglycans and tenascin (Cammarata et 
al., 1986; Danysh and Duncan, 2009). These ECM components provide a physical scaffold to 
ensure structural integrity of the lens capsule and permit lens cell attachment and migration. 
In lens fibrosis, cells over-synthesise and deposit new ECM components, which include 
fibronectin, vitronectin, collagen types I and III; these deposits contribute to the formation of 
fibrotic tissue.  
Cell outgrowths onto vitronectin and fibronectin matrices from explant cultures have been 
reported (Taliana et al., 2006). Cells growing on these substrates had a more 
elongated/fibroblast-like cell appearance, increased αSMA staining and nuclear Smad 
expression. Interestingly these cellular changes were not observed with cell outgrowth from 
explants onto laminin, which retained a more typical epithelial cell phenotype (Taliana et al., 









αSMA expression (Serini et al., 1998). Increased levels of fibronectin production have been 
observed in human lens capsular bag cultures treated wi h TGFβ2 (Eldred et al., 2019; Smith 
et al., 2019; Wormstone et al., 2002). A recent study (Shihan et al., 2020) examined the role 
of fibronectin in fibrotic PCO using a fibronectin conditional knockout mouse model. These 
animals developed a normal lens, but differences emerged when the capsule was ruptured and 
the fibre cells removed to model cataract surgery. The fibrotic response that developed 
following surgery was significantly attenuated beyond 3 days post-surgery and was 
associated with a reduction in cell proliferation, fibrotic extracellular matrix production and 
deposition. Using the Dissociated Chick-Derived Monolayers system (DCDML) it has also 
been shown that plasma-derived fibronectin upregulated TGFβ/Smad signalling and αSMA 
relative to cells plated on laminin (VanSlyke et al., 2018). The proteoglycan lumican has 
been identified in post-mortem capsular bag specimens (Saika et al., 2003). It has been shown 
in lumican knockout mice that following injury to the anterior lens capsule by a needle 
puncture, there was a delay in expression of αSMA and the appearance of transdifferentiated 
cells (Saika et al., 2003).  
 
Secreted protein acidic and rich in cysteine (SPARC) may play a role in lens fibrotic events 
by altering the expression of ECM proteins (Yan and Sage, 1999). Reports indicate that 
SPARC-null mice develop cataracts prematurely due to at enuated growth (Bassuk et al., 
1999). Decreased laminin deposition is also observed in SPARC knockout mice relative to 
wild type lenses (Weaver et al., 2006). Additional studies investigated the effects of TGFβ in 
lens epithelial cells from wild type and SPARC null mice (Gotoh et al., 2007). TGFβ induced 
expression of both fibronectin and αSMA in both groups, but this was more marked in the 
SPARC null group, suggesting SPARC is involved in suppressing TGFβ-induced 









dexamethasone, which correlated with a reduction in fibronectin and collagen type IV, which 
again links well with a role for SPARC and fibronectin in the regulation of 
transdifferentiation events.  
 
3.1.3.1. Growth factor interactions with matrix 
Many growth factors are regulated by matrix interactions. For example, heparin binding to 
FGF,  HGF and VEGF can facilitate interaction with their associated receptors; as a result the 
distribution of heparin sulphate proteoglycans (and potentially other ECM components within 
the lens capsule) could play important roles in  FGF, HGF and VEGF regulated fibrotic 
responses (Aviezer et al., 1994; Eldred et al., 2016; Yayon et al., 1991; Zarnegar and 
Michalopoulos, 1995). In a study by Cerra et al (Cerra et al., 2003), FGF alone could not 
initiate the formation of anterior subcapsular fibrotic plaques, however the severity of 
response observed with TGFβ was significantly increased when FGF was also added. TGFβ 
alone can also bind to several matrix components including decorin and collagen type IV 
(Paralkar et al., 1991). Matrix components within the lens capsule have the capacity to adsorb 
growth factors and thus provide an enriched environme t that is likely to promote fibrotic 
events (Ishida et al., 2005; Wormstone et al., 2006a). Direct presentation of ligands to 
receptors, or through slow release resulting from the capsule by proteolytic cleavage 




Two-way communications between the cell and its underlying matrix is continuous and can 
have a significant influence on the behaviour of the cell. This is generally mediated by 








subunits. The interaction of specific integrins with their corresponding ECM ligands allows 
cells to adhere to and migrate across the ECM (Schwartz, 2001). In addition, integrins 
function as cell signalling hubs that permit signal transduction to and from the 
microenvironment (Schwartz, 2001). Dys-regulation of integrin expression or function can 
give rise to fibrotic changes. 
 
Microarray analysis of the human lens epithelial cell line FHL124 was performed to identify 
which integrins are expressed in human lens epithelial cells and identify those of potential 
importance in lens fibrosis (Dawes et al., 2007b). Baseline expression analysis of β-integrin 
subunits in human lens epithelial cells identified ntegrin β1, β2, β3, β5 and β6 subunits. β1 
integrin subunit was the most abundant. β1 integrin is the most promiscuous integrin subunit 
and is known to associate with 12 different α integrin chains (Elner and Elner, 1996); and is 
the most widely expressed integrin throughout the body (Elner and Elner, 1996). In the lens, 
it has been shown that β1-integrin regulates Erk1/2 and Akt phosphorylation and a loss of β1 
integrin gives rise to elevated expression of early gene response 1 (Egr1), which results in 
apoptosis (Wang et al., 2017).  With respect to the alpha sub-units, baseline expression in 
human lens epithelial cells showed α1, α2, α3, α4, α5, α6, α7, α10, α11, αE, αM, and αV were 
detectable (Dawes et al 2007). TGFβ exposure resulted in increased expression of α5, α11, 
αV and α5 integrin subunits.  
  
α5β1 integrin expression is of particular relevance to fibrotic changes in the lens epithelium. 
α5β1 integrin together with its matrix ligand fibronectin, show enhanced expression 
following TGFβ exposure in both the human capsular bag and human lens epithelial cell line 
(Dawes et al., 2008; Dawes et al., 2007b; Grocott et al., 2007). It is a commonly held view 









al., 1999; Jester et al., 1995). Data obtained from FHL124 lens cell experiments suggest that 
this may not be essential (Dawes et al., 2008; Dawes et al., 2009). Blocking the RGD binding 
site of α5 integrin using RGDS peptide revealed that the fibronectin/fibronectin receptor 
interaction was not essential to promote matrix contraction in response to TGFβ (Dawes et 
al., 2008). In addition, Marcantonio et al (Marcantonio and Reddan, 2004) also showed that 
expression and distribution of α5β1 in FHL124 cells altered in response to TGFβ exposure,  
such that a diffuse pattern was observed across the cell; membrane-bound α5β1 integrin did 
not appear to associate with actin filaments.  
 
Integrin αVβ5 is reported to play an important role in fibrotic pathologies. This is mainly 
because it permits mechanotransduction in response to xtracellular microenvironments 
(Kass et al., 2007) and is implicated in the transdifferentiation of cells to myofibroblasts 
(Lygoe et al., 2004). Exposure of lens epithelial cells to TGFβ gives rise to an increase in 
αVβ5 integrin expression (Dawes et al., 2007b; Grocott et al., 2007) in association with 
increased levels of transdifferentiation markers (Dawes et al., 2008; Wormstone et al., 2002). 
On the basis of these findings, it has been proposed that αVβ5 integrin can play a 
bidirectional role in lens fibrosis (Walker and Menko, 2009). Firstly, it could mediate TGFβ-
induced transdifferentiation following trauma to the lens and secondly, act by facilitating 
signals from myofibroblasts back to the ECM, resulting in the activation of matrix-associated 
TGFβ. Disruption to lens integrity through injury can alter integrin expression in lens 
epithelial cells. Sponer et al (Sponer et al., 2005) showed that expression of αVβ6 integrin 
was up-regulated in cells residing in human capsular bags cultured in protein-free medium 
compared with cultured intact lenses. αVβ6 integrin is reported to play a role in  TGFβ 
activation through its association with an RGD peptide in the latency associated peptide 









the levels of active TGFβ and the formation of microenvironments capable of driving fibrotic 
modifications of lens epithelial cells. αV integrin null mice were used to assess the impact of 
αV integrin on post-surgical fibrotic responses (Mamuya et al., 2014). This work revealed 
that cell proliferation was reduced and expression of fibrotic markers suppressed relative to 
wild type animals. Smad3 was not phosphorylated in null mice thus showing TGFβ/Smad 
signalling is suppressed (Mamuya et al., 2014). 
 
Integrin-linked kinase (ILK), a serine threonine kinase that binds to the cytoplasmic tail of 
alpha and beta integrin subunits, has been detected in l ns cells of both murine and human 
origin (Weaver et al., 2007). ILK is a multidomain focal adhesion protein that regulates ECM 
adhesion and signal transduction. Evidence supports the notion that ILK is a regulator in 
myofibroblast formation (de Iongh et al., 2005; Li et al., 2003; Weaver et al., 2007). 
Expression of ILK in cultured mouse and human lens cells is associated with elevated 
expression of transdifferentiation markers, fibronectin and αSMA. In addition, the 
introduction of ILK-expressing constructs resulted in an altered morphology that was 
fibroblast-like in nature (de Iongh et al., 2005). Exposure of HLE-B3 cells to TGFβ leads to 
increased expression of ILK in association with a loss of the epithelial cell marker E-
cadherin, and increased αSMA protein levels (Zhang and Huang, 2018). ILK siRNA 
knockdown or an ILK inhibitor (QLT0267) prevents these TGFβ-induced effects (Zhang and 
Huang, 2018). Moreover, it has been observed that ILK co-localises with α5β1 integrin; the 
presence of fibronectin further promotes this associati n (Weaver et al., 2007). ILK appears 
to be a potentially important protein in the regulation of transdifferentiation and is likely to 
involve association with integrins and matrix components classically linked with fibrosis. 
Elucidating the role of ILK in the grand scheme of lens fibrotic changes would be an 










3.1.3.3. Matrix metalloproteinases 
Matrix metalloproteinases (MMPs) belong to a larger family of proteases known as the 
metzincin superfamily and are often associated withtissue fibrosis: evidence supports a key 
role in PCO formation (Eldred et al., 2012).  There a  26 MMPs including six membrane-
tethered (MT)-MMPs in addition to four natural MMP inhibitors, the tissue inhibitors of 
MMPs (TIMPs). The MMP and TIMP family members can act on multiple targets and 
perform a variety of functions, which maintain and remodel tissue architecture (Robert et al., 
2016; Sivak and Fini, 2002). The involvement of MMPs in fibrosis seems counterintuitive, as 
the primary role of MMPs is to degrade matrix, while a hallmark of fibrosis is ECM 
accretion. However, MMPs are not limited in function t  simply degrading matrix. Their role 
is far more complex. MMPs can aid the release of grwth factors and cytokines such as FGF-
2 and TGFβ, from the lens capsule and activate macrophages (Imai et al., 1997; Tholozan et 
al., 2007; Yu and Stamenkovic, 2000). MMPs have been reported to play a key role in 
anterior subcapsular cataract, such that MMP inhibitors could attenuate TGFβ-induced 
fibrotic plaque formation in whole rat lens cultures (Dwivedi et al., 2006). In human capsular 
bag cultures, TGFβ2 exposure increased the level of both MMP-2 and -9 in the media 
(Wormstone et al., 2002), which coincided with increased matrix contraction and increase 
myofibroblast detection. Interestingly, bathing media obtained from cultured ex vivo capsular 
bags (donor lenses from patients who have previously had cataract operations) in serum-free 
media, also revealed expression of MMP-2 and -9, indicating that ex vivo capsular bags 
secrete MMPs in a manner similar to TGFβ2-treated cultures  (Wormstone et al., 2002). 
Furthermore, Wong et al. (Wong et al., 2004) found that application of 100µM Ilomostat (a 
broad-specrum MMP inhibitor) significantly reduced cell migration and capsular bag 









store for TGFβ2 (Wormstone et al., 2006a) along with FGF (Tholozan et al., 2007). MMPs 
are reported to release growth factors from the ECM and it is therefore likely that MMPs can 
regulate the degree of matrix-bound and free levels of cytokines available to lens cells over 
extended periods.  
 
Analysis of MMP expression has been performed on the native human lens, primary cultures 
and the FHL124 cell line (Eldred et al., 2012; Hodgkinson et al., 2007). The levels of MMPs 
in the native lens are relatively low with MMP14 the most abundant in the anterior 
epithelium (Hodgkinson et al., 2007). Primary cultured human lens explants demonstrated a 
general increase in expression of MMP family members, but the most notable increases were 
MMP2 and MMP14 (Hodgkinson 2008). Interestingly, gene profiling of FHL124 cells 
demonstrated that MMP2 and MMP14 gene expression was upregulated by TGFβ2 (Eldred et 
al., 2012). This pattern was also observed at the protein level. Inhibition strategies using 
siRNA did not suggest that MMP14 played a role in TGFβ-induced matrix contraction. 
However, siRNA and antibody neutralisation of MMP2 in both FHL124 and human capsular 
bags did indicate MMP2 was important in this process (Eldred et al., 2012). In addition, it has 
been suggested that MMP14 plays a role in MMP2 activ tion from its proform. However, 
MMP14 inhibition did not prevent TGFβ-induced activation of MMP2 (Eldred et al., 2012), 
suggesting other modes of activation are involved.  
 
We have also conducted experiments to assess the potential role of MMPs in the activation of 
TGFβ1 from its latent form. To achieve this we applied commercially available inactive 
latent TGFβ1 to lens cells. To ensure that the application of this molecule was relevant to 
PCO, we first conducted match-paired capsular bag experiments with control cultures 









end-point, matrix contraction/wrinkling was greater with latent TGFβ1 treatment relative to 
controls (Figure 7A). A similar pattern was also observed with αSMA expression (Figure 
7A). Having demonstrated that TGFβ1 could be converted to its active form in the capsular 
bag we applied latent-TGFβ1 to the FHL124 cell line. Again, treatment promoted matrix 
contraction and enhanced αSMA expression (data not shown). We then focused our attention 
on Smad signalling as this provides a direct and rapid measure of ligand/receptor interaction.  
Latent-TGFβ1 was found to promote Smad2/3 translocation to the nucleus within 2 hours. To 
determine if MMPs played a role in this response thbroad-spectrum MMP inhibitor 
GM6001 was applied at 12.5µM, 1 hour prior to latent-TGFβ1 addition. Pre-treatment with 
GM6001 inhibited Smad translocation (Figure 7B & C). A similar outcome was observed 
using MMP2 siRNA knockdown (data not shown). These findings suggest a key role for 
MMP2 in latent-TGFβ activation.  
 
 
3.1.3.4. Advanced glycation end-products 
The proteins that compose the lens capsule, like many other basement membranes, are long-
lived and subject to chemical modifications which accumulate over time. One of these 
modifications, advanced glycation end-products (AGE) (Stitt, 2001) has been investigated in 
relation to PCO. LC‐MS/MS analysis of human capsule samples showed age‐dep ndent 
increases in several AGEs (Raghavan et al., 2016). Moreover, many AGEs are increased in 
cataractous samples. Interestingly, cells cultured on AGE‐modified basement membrane and 
human lens capsule compared with those on unmodified proteins demonstrated an 
upregulation of fibrotic markers in response to TGFβ. Human capsular bag cultures were also 
analysed for AGE content of capsule proteins (Raghavan et al., 2016).  TGFβ2‐induced 









for AGEs (RAGE) are present in lens cells and inhibition of RAGE can suppress TGFβ-
induced αSMA expression (Raghavan and Nagaraj, 2016). This work infers that AGE 
modification of the lens capsule can enhance fibross and would suggest that aged cataract 
patients are likely to have a stronger fibrotic response than their younger counterparts who 
often have a strong regenerative response. This idea is supported (to some degree) by a study 
on explant samples obtained from paediatric cataract surgery (Wernecke et al., 2018).  The 
samples showed greatest levels of outgrowth from neonat s, which diminished with relative 
increases in age. However, αSMA was not significantly enhanced in these young cultures by 
TGFβ2 exposure.  
 
3.2. Regenerative PCO 
The key characteristics of regenerative PCO are the formation of Soemmerring’s ring at the 
periphery of the capsular bag and the generation of Elschnig’s pearls, which are refractive 
structures that can encroach behind the IOL optic and cause visual disturbance. It is known 
that regenerative PCO, and in particular Elschnig’s pearls, contribute more to a loss in visual 
quality than the fibrotic PCO form (Lu et al., 2019; van Bree et al., 2011). Despite the 
importance of regenerative PCO in the clinic, our understanding of the biology that underpins 
its development is poor. 
 
Analysis of post-mortem human clinical samples using transmission and scanning electron 
microscopy has shown evidence of normal and aberrant lens fibre cells within the peripheral 
lens capsular bag (Kappelhof et al., 1987). A similar pattern has been observed using 
histological techniques (Koch et al., 2019). The formation of Soemmerring’s ring in the 
rabbit is also reported, which is generally more developed than in human and its 









nucleated bow fibres both at the equatorial side and djacent to the IOL (Kappelhof et al., 
1985). In some cases, histological sections present a layer of cells on the posterior capsule, 
while in others it is absent (Kappelhof et al., 1987; Koch et al., 2019; Saika et al., 2002). It is 
unclear whether Soemmerring’s ring formation is an extension of lens fibre differentiation 
originating from the lens equator or fibre cell differentiation from the cells lining the 
peripheral posterior capsule; the latter could reflect a pattern of development similar to 
embryological primary fibre cell formation.  
 
Elschnig’s pearls are clinically the most important component of regenerative PCO as they 
can sit within the visual axis and are both irregular and refractive. Elschnig’s pearls are 
globular cells with an extended basal section (Sveinsson, 1993). They contain a nucleus, 
which can range from round to oval to lobulated andvary in general appearance from smooth 
to being covered in microvilli (Findl et al., 2010).  It is also reported that pearls are connected 
by gap junction and desmosome-like structures and co tain few organelles. Elschnig’s pearls 
also share many characteristics associated with lens fibre cells (Sveinsson 1993). Clinical 
studies (Findl et al., 2010) have demonstrated that Elschnig’s pearls can be dynamic. Findl et 
al (Findl et al., 2010) assessed over 6000 pearls in 85 eyes and found constant change over 
the period of observation. Initially the pearls were small, but continued to grow in volume, 
fragment or shrink.  
 
It has been reported that cultured human lens capsul r bags accrue material in the peripheral 
bag, which could indicate that some level of fibre cell differentiation is initiated; however, 
these preparations did not mature into well-defined Soemmerring’s rings (Koch et al., 2019). 
Nevertheless continued development of the capsular bag system to better model regenerative 










Rat lens epithelial explants undergo fibre cell differentiation in response to high levels of 
FGF and vitreous humour (Chamberlain and McAvoy, 1989; West-Mays et al., 2010). A 
modification to the rat lens explant system produce v ry interesting data that is relevant to 
Soemmerring’s ring formation (O'Connor and McAvoy, 2007). In this case, the explants were 
cultured as pairs, one on top of the other with the ant rior epithelium of each explant adjacent 
to one another. The cultures were maintained in Medium 199 containing bovine vitreous 
humour, which is rich in FGF. These paired explants underwent fibre differentiation and 
formed convex lens structures that had light-focusing ability. The peripheral fibre cells 
presented markers for early stages of fibre differentiation, while the central cells contained 
markers of terminally differentiated fibres. Interestingly, following long-term culture, opacity 
developed in the central region of the lens-like structure. This study has great relevance to 
PCO as the anterior and posterior capsules of the capsular bag come in close contact. As cells 
populated the posterior capsule and became stable following the initial period of growth, the 
scenario was very similar to the paired explant sysem in the capsular bag and is likely to 
follow a similar developmental path.  
 
In vivo PCO animal model studies report the presence of Soemmerring’s ring (Lois et al., 
2003; Zukin et al., 2019; Zukin et al., 2018). At present, these models have not been fully 
exploited to understand the mechanisms driving Soemm rring’s ring formation, but a recent 
study has suggested that aldose reductase inhibition could promote its formation (Zukin et al., 
2019). Moreover, in the rat, electrical fields play an important role in lens regeneration (Lois 
et al., 2010) following fibre cell removal. In the rabbit, the influence of biodegradable and 











Primary cell culture systems can also be used to generate lentoids (Boswell et al., 2017; Lin 
et al., 2016). Neonatal rabbit cultures can establish lentoids that have magnifying properties 
and express fibre cell markers, β and γ crystallin (Lin et al., 2016). This same group reported 
the presence of stem cells (Lin et al., 2016). Dissociated cell-derived monolayer chick lens 
cultures have been used to demonstrate that in addition to its ability to induce 
transdifferentiation of lens epithelial cells to myofibroblasts, TGFβ can also promote lens cell 
fibre differentiation. This response was blocked by rapamycin, which links mTOR signalling 
to induction of fibre cell differentiation by TGFβ (Boswell et al., 2017).  
 
Lens regeneration has been well studied in urodeles, but has become increasingly relevant in 
mammals (Kumar and Reilly, 2020) with much of our basic understanding of lens fibre cell 
differentiation formed from developmental biology (Lovicu et al., 2011). A great deal of 
information can be drawn from developmental systems and translated to the study of human 
lens fibre cell differentiation in relation to regenerative PCO. A number of growth factors and 
cell signalling pathways have been identified to regulate fibre cell differentiation, which 
include BMPs, TGFβs, Notch, Wnts and FGFs (Lovicu et al., 2011). The central figures in 
fibre cell differentiation are the FGFs, which seem to be crucial for initiation of fibre cell 
differentiation in mammals (Lovicu et al., 2011).  This information was utilised to great 
effect to establish lens organoid formation from embryonic stem cells through sequential 
inhibition and activation of FGF, TGFβ and Wnt signalling (Yang et al., 2010); this is a 
superb example of translating animal studies to a human platform. This also suggests that the 
major regulatory systems of fibre cell differentiation are relatively well conserved across 
mammalian species. Incremental refinement of these sy tems has increased the efficiency of 









environment (Fu et al., 2017; Murphy et al., 2018) (Figure 3). Stem cell-derived lentoids 
could form a major study tool to characterise successful and aberrant fibre cell differentiation 
in relation to human PCO.  
 
 
4.  Management and prevention of PCO 
4.1. Intraocular implants 
It is important to remember that PCO is driven by wound-healing events, triggered by the 
trauma of cataract surgery. Nevertheless, an IOL can influence the path of PCO progression 
and serves as a valuable tool in the management of PCO. Over the past few decades, IOLs 
have emerged in many forms, constructed from a range of materials. At present the most 
commonly implanted IOLs are foldable square-edged IOLs with looped haptics. In the 
following text, we will discuss features associated with standard IOL designs and describe 
alternative design concepts for PCO prevention. 
 
4.1.1. The barrier effect 
The Alcon Acrysof™ IOL was the first commercial IOL to have a square-edge optic profile. 
While grand statements were made to suggest that the introduction of this IOL had eradicated 
PCO (Apple et al., 2001) proved unfounded, the notio  that rates of PCO and Nd:YAG 
capsulotomy were reduced relative to other IOLs was justified (Perez-Vives, 2018). The 
improvement in patient outcome is attributed to thesquare-edge profile. A square-edge 
profile is now a common feature of commercial IOLs, however it is argued that the 
manufacture of the edge can differ such that some IOLs have a sharper edge than others, 
which can influence the outcome (Perez-Vives, 2018). A major topic of debate is the material 









1997), while others argue that the benefits of a square-edge are independent of material 
(Nishi, 1999).  
 
Linnola (Linnola, 1997) presented the Sandwich Theory of PCO to provide a mechanism by 
which a hydrophobic acrylic IOL with a square-edge optic (such as the Alcon Acrysof™) 
could reduce PCO progression. This theory presents the case that the IOL material can 
exhibit biocompatibility in a bioinert or bioactive manner. It is argued that hydrophobic 
acrylic material provides benefit through a bioactive principle. It is proposed that cells grow 
across the posterior capsule following surgery and e counter the optic edge. This provides 
some impedance to growth, but cells still progress behind the optic. If the cell population on 
the posterior capsule remains as a homogenous monolayer, its impact on light scatter is 
reduced. It is proposed that the bioactive material n bles cells to adhere to both the IOL and 
the capsule, such that cells form a ‘sandwich’ betwe n these layers. This tight adhesion and 
close apposition of the capsule to the IOL is believ d to increase the barrier function and 
reduce further cell movement below the optic. The bioactive component identified to support 
this theory is the matrix component fibronectin, which is reported to be the key biological 
component that enables adhesion between the IOL, cells and capsule. The major evidence to 
support this idea is histological assessment of post-mortem capsular bag samples and IOLs 
removed from post-mortem capsular bags (Linnola et al., 2000a, b). Unfortunately, it is 
difficult to draw any meaningful conclusion from these data as samples were fixed prior to 
IOL removal. In such circumstances, fixation provides strong bonds between the biological 
material and the IOL. To assess if cell and matrix accumulation on the IOL has taken place 
the IOL needs to be removed prior to fixation and then undergo histological analysis. Recent 
work using the human capsular bags has illustrated that the major site of cell growth on 









that if cells have a choice between the native capsule and an IOL they will choose the more 
complete natural substrate. This therefore suggests tha  IOL materials are unlikely to enhance 
the barrier effect through a bioactive biocompatibili y mechanism. Work by Nishi (Nishi, 
1999) demonstrated that a square-edge optic offered benefit regardless of material, which 
again suggests this is a physical phenomenon indepent of material that could be enhanced 
by design features, such as haptic shape/angulation nd the manufacturing process employed 
to generate the square-edge profile. 
 
4.1.2. Open-bag IOLs 
Standard IOL designs produce a closed bag system where the lens capsule is in close 
apposition to the IOL. In contrast, open bag devices partition the anterior and posterior 
capsules (Figure 8). This is proposed to allow irrigation of the capsular bag and diminish the 
impact of growth factors on PCO progression (Eldred et al., 2016; Eldred et al., 2014). 
Capsular ring devices implanted during cataract surgery have been tested in animal systems 
and human patients. These ring systems can house a standard IOL and show a marked 
reduction in PCO incidence (Alon et al., 2014; Hara et al., 2011; Hara et al., 1995). Recent 
reports have suggested that introduction of a square edge capsular ring and increasing 
apertures in the wall of the ring implant provide optimal outcomes when assessing PCO in a 
rabbit in vivo model (Slutzky and Kleinmann, 2018). The Anew Zephyr™ open-bag IOL is a 
disk-shaped 1-piece hydrophilic acrylic monofocal device that provides refractive correction 
and separation of the anterior and posterior capsules in a single device.  Introduction of the 
Anew Zephyr™ IOL has been found to reduce PCO progression relative to Alcon Acrysof™ 
closed bag IOLS, in a suspended human lens capsular bag model (Eldred et al., 2019). 









even 6 months following surgery, whereas control eyes implanted with Alcon Acrysof™ 
IOLs presented severe PCO in all cases (Aliancy et al., 2018). 
 
 
4.1.3. The bag-in-the-lens IOL 
In contrast to conventional surgery, which requires a ingle opening in the anterior capsule, 
the bag-in-the-lens (BIL) technique requires making an opening of the same size in the 
anterior and posterior lens capsules (De Groot et al., 2005; Tassignon et al., 2002). The edges 
of the capsule openings are slotted into a groove at the periphery of the IOL in a similar 
manner to a tyre being introduced to a wheel. According to this concept, if both capsules are 
placed in the groove and are well stretched around the optic of the IOL, any lens epithelial 
cells will be captured within the remaining space of the capsular bag and their growth will be 
limited to this space, so the visual axis can remain clear. This concept was first tested using 
the human capsular bag model (De Groot et al., 2005; Tassignon et al., 2002) and it was 
found that over a six week culture period cells did not proliferate and migrate across the IOL 
i.e. the cells were retained within the remaining capsular bag. A rabbit model was used for in 
vivo evaluation and again cells were retained within the residual capsule (De Groot et al., 
2005; Tassignon et al., 2002). Significant numbers of BIL IOLs have been implanted and the 
outcomes are impressive. The introduction of BIL IOLs is particularly relevant to paediatric 
patients, who have rapid onset of PCO. Successful imp antation of a BIL IOL prevented 
PCO, even in these extreme paediatric cases (Tassignon et al., 2007). The limiting factor in 
the uptake of this approach is the level of skill required by the surgeon to carry out this 
procedure. However, instructional courses are availble along with an international panel of 
BIL instructors who can pass on their knowledge anddemonstrate the technique. Currently, 









long-term) continue to demonstrate excellent outcomes, particularly for children, this 
approach is likely to be adopted more readily by additional countries. 
4.2. Alternative surgery 
Previous work has shown that in animal systems lensr generation can occur following 
cataract surgery, but this is reliant on retention of the anterior lens epithelium and capsule 
(Gwon and Gruber, 2010; Lois et al., 2010).  Building on this work, Lin et al (Lin et al., 
2016) employed a small, off-set opening in the anterior capsule and retention of the lens 
epithelial cells that could facilitate regeneration f a new lens from endogenous stem cells 
within the epithelial cell population. This work was carried out on infants who presented 
congenital cataract (present from birth). There was clear evidence that some level of lens 
regeneration occurred and provided some benefit to these patients. However, a number of 
issues need to be considered when contemplating this approach as an alternative for 
conventional surgery. The capacity to repair and regen rate is faster in the young and several 
months elapsed to see some level of visual improvement. In older patients (i.e. the vast 
majority of cataract patients), the ability to reform a lens will be significantly slower and less 
likely to be successful. 
For this new form of surgery to be successful, the regenerated lens will need to closely reflect 
the normal healthy human lens and do so relatively quickly; otherwise, further care will be 
required. Lens regeneration surgery holds great promise, but at present has significant 
limitations and ethical concerns that prevents mass introduction of this technique for cataract 










4.3. Pharmacological treatment 
Despite major advances in the design of IOLs and small incision surgery, PCO still remains a 
significant problem, both from a patient wellbeing perspective and as an economic burden to 
healthcare providers (Brown et al., 2013). It would therefore seem logical that 
pharmacological intervention in concert with optimal IOL design should offer the best 
opportunity to provide a sustained clinical benefit from cataract surgery. A recent study that 
surveyed both human and veterinary ophthalmologists revealed that the majority of 
practitioners were in favour of this approach (Shihan et al., 2019). A number of approaches 
can be adopted that target specific PCO-related events. The vast majority of proposed 
strategies address fibrotic PCO and are generally concerned with controlling the 
inflammatory response to reduce the initial stimulus provided by enrichment of the ocular 
environment; preventing proliferation and migration across the posterior capsule; prevention 
of myofibroblast transdifferentiation and matrix contraction, which usually involves targeting 
TGFβ signalling or pathways regulating this system.  
 
Non-steroidal and steroidal anti-inflammatory drugs are routinely used in surgery.  However, 
in relation to PCO little benefit has been demonstrated (Laurell and Zetterstrom, 2002). 
Indeed, it was actually found that anti-inflammatory treatment of patients undergoing cataract 
removal surgery resulted in a higher number of patients developing fibrotic PCO 4 years 
post-surgery than subjects treated with a placebo. A recent study, however, has suggested that 
a combined application of non-steroidal and steroidal anti-inflammatory drugs could more 
effectively lower PCO incidence relative to single drug treatments (Hecht et al., 2020).  
Moreover, Symonds et al (Symonds et al., 2006) demonstrated that the steroid 
dexamethasone, which is routinely administered to patients undergoing cataract surgery, 









PCO. This study, therefore, suggests that lens cells are susceptible to the actions of anti-
inflammatory molecules. Chandler et al (Chandler et al., 2007) tested the direct actions of 
cyclooxygenase 2 (COX-2) through application of COX-2 inhibitors rofecoxib or celecoxib, 
to canine capsular bags; both inhibitors suppressed PCO. A clinical trial was performed in 
dogs to compare celecoxib-impregnated IOLS against Bromofenac treatment (Brookshire et 
al., 2015). The Celecoxib-IOL showed better initial control of PCO (up to 12 weeks), while 
eyes that received bromfenac had better long-term control of PCO (56 weeks).  
 
In terms of regulating cell growth across the posterior capsule, there are many candidates for 
drug targetting. The lens has a strong autocrine system that ensures baseline growth is 
relatively strong (Eldred et al., 2016). Inhibition studies in the human capsular bag have 
shown that inhibition of FGF, EGF and VEGF signalling (among others) can slow growth, 
but not completely prevent it (Eldred et al., 2016; Maidment et al., 2004; Wertheimer et al., 
2015b; Wormstone et al., 2001). This suggests that mul iple autocrine signalling pathways 
can contribute to PCO. Therefore, pathway inhibition may be more effective than targeting 
specific receptors, as it could suppress stimulation fr m multiple growth factors. 
 
A number of the strategies proposed to prevent PCO concentrate on preventing TGFβ-
induced fibrotic events (Eldred et al., 2011; Nibourg et al., 2015; Saika et al., 2008); in the 
majority of cases the major focus is on the ability of a given drug to prevent myofibroblast 
formation (Eldred et al., 2012; Nam et al., 2020; Smith et al., 2019; Zukin et al., 2018). It has 
also been reported that there is a sub-population of polyploid mesenchymal progenitors cells 
within the chick lens epithelium (Walker et al., 2010) and it is suggested that these cells could 
be a primary source of myofibroblasts following catar ct surgery and therefore contribute to 








identified in the human lens epithelium (Gerhart et al., 2014), and antibody drug conjugates 
have been developed to specifically eliminate this population of cells (Gerhart et al., 2017; 
Gerhart et al., 2019). It is important to note that in relation to PCO the major light scattering 
element within fibrosis results from matrix deformation, which is generally referred to as 
matrix wrinkling (van Bree et al., 2011). It is generally assumed that transdifferentiation to a 
myofibroblasts is a pre-requisite for matrix contrac ion (Shu and Lovicu, 2017). This concept 
is based on the principle that myofibroblasts assembl  an integrin, fibronectin and αSMA 
contractile apparatus, which leads to matrix contraction (Shu and Lovicu, 2017). This may be 
true in some systems, but work with FHL124 cells suggests this may not be essential in the 
lens (Dawes et al., 2008; Dawes et al., 2009). Therefore, it is important to consider the impact 
on matrix contraction, rather than solely concentrating on EMT, when developing and 
evaluating anti-TGFβ/fibrotic strategies to manage PCO. Furthermore, th ability of aldose 
reductase inhibition on PCO formation was recently assessed (Zukin et al., 2019; Zukin et al., 
2018). In a mouse model of PCO, genetic and chemical inhibition of aldose reductase could 
suppress surgical induced events associated with fibrotic PCO (Zukin et al., 2018), however 
Soemmerring’s ring formation was enhanced (Zukin et al., 2019). This is an important 
finding as it suggests suppression of fibrotic PCO or at least transdifferentiation to 
myofibroblasts could in turn promote the formation f regenerative PCO, which is likely to 
play a greater role in visual deterioration.  
 
As an alternative, complete ablation of the lens cell population is a viable strategy (D'Antin et 
al., 2018; Duncan et al., 2007; Duncan et al., 1997; Liu et al., 2017; Zhang et al., 2019), but it 
is critical that non-lenticular tissues are unaffected by any putative treatment (Duncan et al., 









of an IOL in an acellular capsular bag (Spalton et al., 2014); however, modification of haptic 
designs to improve positioning within the bag may address these concerns. 
 
Regardless of the approach adopted, it is important that an appropriate drug dose be delivered 
over a specific period to provide efficacy. Ultimately, a drug needs to reach the target cells at 
sufficient concentration to work.  Utilising drug delivery strategies is an important 
consideration and area of development. The drug delivery possibilities include direct 
injection into the anterior chamber; modification of the irrigating medium; modification of 
the IOL/capsular tension ring; application using a closed-bag drug delivery device. 
 
One mode of delivery is via the IOL. This approach has been considered over the past three 
decades and is becoming increasingly more sophisticated. Early drug modulation of the IOL 
included an FGF-saporin complex bound to a heparin surface modified IOL, which was 
tested in rabbits (Behar-Cohen et al., 1995). When in contact with the cells, FGF binds to the 
appropriate receptors on the epithelial cells and internalises the saporin, subsequently killing 
the cells. This particular system produced some sid effects, including transient corneal 
oedema and iris depigmentation. Duncan et al (Duncan et al., 1997) showed, using a human 
capsular bag model, that thapsigargin (a specific inhib tor of the endoplasmic reticulum 
CaATPase) when directly coated onto a PMMA IOL can effectively kill the entire cell 
population within the bag. However, this was a simple coating procedure and does not 
account for additional stresses associated with in vivo surgery e.g. entry through the 
corneal/scleral tunnel. Therefore, a drug release sy tem that is both physically robust and 
provides appropriate drug delivery is necessary. Strategies now include impregnating the IOL 
(Bouledjouidja et al., 2016; Brookshire et al., 2015; Wertheimer et al., 2015a). This has 









incorporation of any drug does not disrupt the light path through the IOL. A recent study 
(Ongkasin et al., 2020) reported that an impregnated IOL provided a sustained release of 
methotrexate for 80 days. The methotrexate-impregnat d IOL was tested in the human 
capsular bag model and found to reduce αSMA expression, but did not significantly inhibit 
growth across the posterior capsule. Similar approaches have been developed for use in 
tension rings and one example reports a photodynamic regulated drug release from an IOL 
(Zhang et al., 2016). 
 
An alternative therapeutic approach is to use a closed bag drug delivery system, such as the 
perfect capsule device, which permits high concentrations to be delivered to cells within the 
capsular bag for a designated period and then removd (Maloof et al., 2005). Duncan et al 
(Duncan et al., 2007) tested various agents, applied for a 2-minute period, in human capsular 
bags using this drug delivery system. Treatments included distilled water, 3M sodium 
chloride, 5-Fluorouracil (5-FU) (250ug/ml and 25mg/l) and thapsigargin. Assessment of 
growth on the posterior capsule revealed greatest effect with thapsigargin and 5-FU, however 
in the case of 5-FU treated bags, cells were growing o  the peripheral posterior capsule 
beneath the anterior capsule; no viable cells at all were observed in thapsigargin treated bags. 
In this in vitro study, distilled water was not found to significantly influence events in the 
capsular bag and interestingly when distilled water was applied in the clinic using the perfect 
capsule device this outcome was also observed (Rabsilber et al., 2007). A recent study also 
applied osmotic challenge to the cells within the capsular bag, but included a Na-K-Cl co-
transporter inhibitor to prevent recovery; these results look promising (Zhang et al., 2019). 
 









PCO remains an important problem following cataract surgery. Both fibrosis and attempted 
lens regeneration can contribute to reduced visual q lity in patients. However, the latter 
plays a greater role in visual disturbance. We have a wealth of resources and tools available 
that will aid advances in our understanding of PCO biology, which will enable better 
selection of putative agents to inhibit or prevent PCO formation. IOL designs continue to 
improve through greater appreciation of their influence on lens cell behaviour and PCO 
formation. A combination of improved IOL design and pharmacological treatment is likely to 
provide the best outcome for patients in the future and improved drug delivery strategies 
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Figure 1. PCO development following cataract surgery. A Schematic diagram illustrating (A) 
the capsular bag immediately post-surgery, (B) development of fibrotic PCO showing 
invasion of the posterior capsule and matrix deformation/capsular wrinkling and (C) the 
changes that result from a combination of fibrotic and regenerative PCO with formation of 
Elschnig’s pearls and Soemmerring’s ring. 
 
Figure 2. The suspended human capsular bag model for IOL evaluation. Representative 
modified dark-field images of match-paired capsular b gs implanted with a Hoya Vivinex or 
an Alcon Acrysof IOL captured on the day of simulated surgery. In both cases the 
capsulorhexis (arrowed) is fully seated on the IOL optic. (Eldred et al., 2019). 
 
Figure 3. Lentoid generation from iPSC cultures using iMatrix-511 as a culture substrate. (A) 
Images showing progression of naive iPSCs to lentoids. Images depict Days 0, 6, 9, 16 and 
21 days of culture. All images were captured using a Nikon Ti2 inverted light microscope. 
Scale bar represents 100µm for Day 0 and 250 µm for all ther days. (B) Quantitative graphs 
showing real-time PCR data obtained for key marker g nes over the course of the 
experiments. The x-axis marks the sample time-points i.e. Days 0, 6, 12, 16 and 18 and the y-
axis denotes the relative fold-change of each gene's RNA transcript over time. Note that the 
data has been adjusted such that the Day 0 values for ach gene equals 1. All subsequent data 
points are thus relative and comparable to Day 0.  
 
Figure 4. A schematic outline of (A) sequential events following cataract surgery that can 
ultimately give rise to PCO and (B) the relationship between selected growth factors and 
functional events associated with fibrotic and regenerative PCO. HGF – hepatocyte growth 









epidermal growth factor; TGFβ – transforming growth factor β; BMP – bone morphogenic 
protein; EMT – epithelial to myofibroblast transdifferentiation; MET – myofibroblast to 
epithelial transdifferentiation. 
 
Figure 5. Induction of fibrotic responses in a human c psular bag model. (A) Representative 
epifluorescence micrographs showing the distribution of the myofibroblast marker, α-smooth 
muscle actin and the matrix component, fibronectin associated with cells growing on the 
central posterior capsule of human lens capsular bag preparations maintained in SF or graded 
culture conditions. Images were captured at endpoint (day 28). (B) Pooled data showing 
quantitative αSMA and fibronectin expression in association with cells growing on the 
central PC of capsular bags maintained in serum-free o  graded culture conditions. Data are 
presented as mean ± SD (n = 5). *Indicates a significa t difference between groups 
(Student’s t-test; P≤ 0.05). (Eldred et al., 2019). 
 
Figure 6. Time-dependent sensitivity to TGFβ in the human lens epithelium. Fluorescent 
micrographs showing Smad2/3 translocation in human lens epithelial explant cultures 
immediately following dissection or following culture periods of 6, 24 or 48 hours in serum-
free medium with 10ng/ml added to the medium for the final 2 hours of culture. Scale bar 
represents 100µm. 
 
Figure 7. Human lens cells can activate TGFβ.  Latent-TGFβ1 can be activated by lens cells 
and is MMP dependent (A) Modified darkfield images captured following 28 days culture 
maintained in serum free medium or treated with 10ng/ml latent TGFβ1 showing matrix 
deformation of the posterior capsule and fluorescence micrographs showing an associated 









indicate the capsulorhexis margin. (B)  Fluorescent micrographs showing inhibition of MMPs 
prevents Smad2/3 nuclear translocation in FHL124 cells. FHL124 cells were either untreated 
(control), or pre-treated with the MMP inhibitor GM6001(12.5µM), followed by addition of 
latent TGFβ1 for 2 hours. (C) Nuclear Smad2/3 was quantified from fluorescent micrographs. 
*indicates significant difference, p<0.05, ANOVA with post hoc Tukey’s test (n=3).  
 
Figure 8. A schematic diagram illustrating the positi n of (A) a conventional square-edged 
IOL and (B) the open-bag Anew Zephyr IOL within the capsular bag and how their physical 
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